Is dengue virus another viral trigger for SARDS?
Systemic inflammatory rheumatic diseases (SARDS) are often linked to a trigger by a viral infection such as Epstein-Bar Virus and cytomegalovirus. According to a new …
News and Views
Cardiovascular and malignancy risk with janus kinase inhibitor is it dose dependent
Janus kinase (JAK) inhibitors, a new class of targeted synthetic disease-modifying antirheumatic medicines (DMARDs), have been demonstrated to be safe and effective in rheumatoid arthritis …
Finally! a definition for difficult-to-treat rheumatoid arthritis
A recent study published in the Annals of Rheumatic Diseases has proposed European League Against Rheumatism (EULAR) definition for difficult-to-treat RA, which could be beneficial …
Risk of COVID-19 infection with Interstitial Lung Disease
Interstitial lung disease ILD is a wide range of conditions, and the majority of them result in progressive scarring of lung tissue. This in turn …
Patients treated with anti- B cell therapy have a higher risk of COVID -19 death
B cells play a crucial role in the pathogenesis of many autoimmune diseases. Selective targeting of those cells has recently been achieved by chimeric antibody …
Is rheumatoid arthritis two different diseases?
Rheumatoid arthritis (RA) is a persistent inflammatory ailment of the joints. It is an autoimmune disease, most commonly affecting the joints of the hands, wrists, …
Should we vaccinate high risk rheumatic disease with third booster dose?
A COVID-19 booster is an extra dose of vaccine given after the protection from the first injection (s) wears off over time. After immunity from …
Should child with arthritis be prioritized and get Covid-19 vaccine
As a major boost to India’s fight against COVID-19, the Subject Matter Expert Committee has given the Controller General of Drugs of India (DCGI) a …
You must be logged in to post a comment.